The 17th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.
Across 150 sessions, you will learn from leading experts across the issues most impacting on the wider vaccine sector, as well as delve into your specialist area of research and job focus in co-located conferences. Build three days of totally tailored content and attendees.
Meet over 700 of your peers in one room and take advantage of the multiple extended networking breaks, co-located World Vaccine Congress (including 7 streams on Immune Profiling, Cancer & Immunotherapy, Influenza & Respiratory, Clinical Trials, Emerging Diseases, Partnerships, Veterinary Vaccines and Bioprocessing & Manufacturing) as well as the evening drinks reception
Key speakers include:
- Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
- Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine
- Dr Alessandro Sette, Center Head, Division Head, and Professor Center for Infectious Disease, La Jolla Institute
- Prof Mark Davis, the Burt and Marion Avery Family Professor, Microbiology & Immunology, Stanford University
- Prof Bali Pulendran, Professor in the Department of Pathology and Laboratory Medicine, Emory University School of Medicine
- Dr Peter Hotez, President of the Sabin Vaccine Institute & Dean of National School of Tropical Medicine, Baylor College of Medicine
- Dr Penny Heaton, Director of Vaccine Development, Global Health Program, The Bill and Melinda Gates Foundation
- Dr Jerald Sadoff, Senior Advisor to CEO, Janssen Infectious Diseases and Vaccines
- Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK
- Dr George Siber, Exec Director, CSO of ClearPath Vaccines & Chair of Scientific Advisory Board, Genocea Biosciences Inc
- Dr Cyril Gay, Senior National Program Leader, Office of National Programs, USDA
- Dr Vasee Moorthy, Team Leader, Vaccine Development Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, WHO
- Dr Marion F. Gruber, Director, OVRR, CBER, FDA
- Dr Ripley Ballou, VP & Head, GSK Global Vaccines US R&D Center, GSK Vaccines
- Dr Bruce Gellin, NVAC Executive Secretary, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services
- Dr Kathrin Jansen, Senior Vice President & Head Vaccine Research & Development, Pfizer
- Prof Alan R. Hinman, Director for Programs, Center for Vaccine Equity, Adjunct Professor of Global Health and Epidemiology, Task Force for Global Health
- Dr Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly